CHINA HAS EMBRACED A VIGOROUSLY GROWING HEALTHCARE MARKET IN THE PAST
DECADE. Ever since joining ICH in 2017, CHINA HAS SEEN INCREASED
CLINICAL TRIALS AND ACCELERATED NEW DRUG AND DEVICE APPROVAL. For
biotech and MedTech companies outside of CHINA, you need to find the
right partners and the right resources to bring your products to
CHINA, in order to adapt to the difference in culture, regulation,
reimbursement, etc. In the meantime, Chinese biotechs are actively
seeking global market entry opportunities and overseas partners.
China Focus @BWB is designed to provide a meaningful platform to
inform, inspire, and foster cross-border partnership in life science
and healthcare.
business
1035
Views
23/09/2020 Last update